Delivery Order SPE2DB22D2006-SPE2DB25FW3AV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $66,055.04 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the company's...
- The Defense Logistics Agency awarded a $134,778.88 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This firm fixed-price delivery order, issued on July 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, operates under firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award to...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on July 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a $94,770.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,042.56 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and requires performance at the contractor's Conshohocken, Pennsylvania facility. This is an unset-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal vaccine...
- The Defense Logistics Agency has awarded a delivery order valued at $30,963.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, carries a firm fixed price and has an ultimate completion date of August 26, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion deadline of August 21, 2025. This is a firm fixed price, non-set-aside contract, with performance based in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, demonstrating the company's role as a critical vaccine...
- The Defense Logistics Agency awarded a delivery order valued at $3,158.88 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract was competitively awarded without set-aside provisions and carries an ultimate completion date of August 21, 2025. The award was issued on July 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents one of numerous...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3AVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $46,444.95 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages its comprehensive indefinite delivery contract with DLA valued at $999,999,999.00 through December 2026 to fulfill diverse military and veteran healthcare pharmaceutical supply needs. This specific delivery order for Varivax vaccine demonstrates the company's role in supporting military health readiness through the provision of immunization products and other essential pharmaceutical commodities. The contract exemplifies DLA's strategy of utilizing prime vendor agreements to ensure flexible, efficient procurement of medical supplies for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.4k | 8/1/25 |